Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
NCT01110200
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
639
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
ADVAIR DISKUS 250/50 mg BID
DRUG:
SEREVENT 50 mcg BID
Sponsor
GlaxoSmithKline